Comparative analysis of scaffold-free tissue-engineered cartilage derived from different seed cells: in vitro and in vivo studies
Stem Cells Translational Medicine · 2025
DOI: 10.1093/stcltm/szaf057 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Stem Cells Translational Medicine, 2025. Verfasst von Mengxin Xue und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, C…. Hauptthemen laut MEDLINE: Tissue Engineering, Mesenchymal Stem Cells, Chondrocytes, Cartilage, Articular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai Municipal Health Commission Key Priority Discipline Project, Shanghai Spinal Disease and Trauma Orthopedics Research Center, Quanzhou City Science & Technology Program of China.
Abstract (Originalsprache)
Objective
The development of cartilage tissue engineering offers a promising strategy for effective cartilage regeneration. This study aims to synthesize scaffold-free tissue-engineered cartilage (TEC) using articular chondrocytes (ACs), costal chondrocytes (CCs), bone marrow mesenchymal stem cells (BMSCs), and synovial-derived mesenchymal stromal cells (SDSCs) as seed cells, comparing their cartilage matrix production in vitro and repair capabilities in vivo to guide seed cell selection.
Methods
ACs, CCs, BMSCs, and SDSCs were seeded at high density (4.0 × 105 cells/cm2) in 24-well plates with 0.2 mM Ascorbate 2-phosphate and cultured to form scaffold-free TEC. In vitro, we performed real-time polymerase chain reaction (RT-qPCR), biological analyses, and histochemical staining to assess structural characteristics and cartilage-related gene expression. In vivo, a rat model of knee cartilage defect was used to evaluate tissue repair capabilities, followed by histological assessments and statistical analysis.
Results
In vitro, ACs and CCs showed significantly higher GAG/DNA ratios, with CCs exhibiting the highest chondrogenic gene expression. Histological analysis revealed AC and CC TECs were positive for Safranin-O, Alcian blue, and Col2 staining. In vivo, CC-derived TEC maintained a uniform distribution of Col2, while BMSCs and SDSCs primarily showed Col1 distribution, demonstrating better integration with cartilage and in situ differentiation by 12 weeks.
Conclusion
ACs and CCs excelled in cartilage matrix synthesis; however, AC TEC exhibited phenotypic instability. CC TEC sustained a hyaline chondrocyte phenotype but had later connectivity issues, while BMSCs and SDSCs integrated better but primarily produced fibrous tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
- Department of Orthopedics, Shanghai Sixth People's Hospital Fujian, Jinjiang City, Fujian Province 362200, China.
ORCID-Profile: Kaiwen Zheng
Förderung
- Shanghai Municipal Health Commission Key Priority Discipline Project, Shanghai Spinal Disease and Trauma Orthopedics Research Center
- Quanzhou City Science & Technology Program of China
Zitieren
APA
Xue, M., Zheng, K., Chen, J., Zheng, C., Liu, X., Zhang, C., & Du, D. (2025). Comparative analysis of scaffold-free tissue-engineered cartilage derived from different seed cells: in vitro and in vivo studies. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szaf057
Vancouver
Xue M, Zheng K, Chen J, Zheng C, Liu X, Zhang C, et al. Comparative analysis of scaffold-free tissue-engineered cartilage derived from different seed cells: in vitro and in vivo studies. Stem Cells Translational Medicine. 2025. doi:10.1093/stcltm/szaf057
BibTeX
@article{Xue2025,
author = {Xue, Mengxin and Zheng, Kaiwen and Chen, Jiewei and Zheng, Che and Liu, Xiaofeng and Zhang, Changqing and Du, Dajiang},
title = {Comparative analysis of scaffold-free tissue-engineered cartilage derived from different seed cells: in vitro and in vivo studies},
journal = {Stem Cells Translational Medicine},
year = {2025},
doi = {10.1093/stcltm/szaf057}
}
EUVIMED